8.320USD+4.00%Mkt Cap: 792.67M USDP/E: —Last update: 2026-05-26
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
54.95BSEKP/E 101.9
53.92BSEKP/E 22.9
52.13BDKKP/E 22.1
50.54BUSDP/E 47.4
39.31BEURP/E 18.6
Indicators:|
Key Statistics
Company
Market Cap792.67M USD
Enterprise Value1.70B USD
Revenue (TTM)1.03B USD
Gross Profit157.56M USD
Net Income (TTM)-47.10M USD
Revenue/Share13.28 USD
Last Price8.320 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.1K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)8.52
PEG—
EV/EBITDA19.85
EV/Revenue1.65
P/S0.76
P/B1.34
EPS (TTM)-0.39
EPS (Forward)0.96
52W Range
6.45014% of range19.45
52W High19.45 USD
52W Low6.450 USD
Profitability
Gross Margin15.40%
Oper. Margin3.51%
EBITDA Margin8.32%
Profit Margin-4.60%
ROE-8.04%
ROA-2.67%
Growth
Revenue Growth3.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF17.07M USD
CapEx (TTM)23.48M USD
FCF Margin—
FCF Yield—
Net Debt916.22M USD
Net Debt/EBITDA10.68
Balance Sheet
Debt/Equity1.64
Current Ratio1.41
Quick Ratio1.30
Book Value/Sh6.098 USD
Cash/Share0.5330 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)18.00 USD
Target Range9.000 USD – 23.00 USD
# Analysts7
Ownership
Shares Out.96.08M
Float22.16M
Insiders81.06%
Institutions34.41%
Short Interest
Short Ratio3.8d
Short % Float12.43%
Short % Out.3.34%
Shares Short3.21M
Short (prev mo.)3.22M
Technical
SMA 509.690 (-14.1%)
SMA 20012.81 (-35.0%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)1.00M
Avg Vol (10d)1.65M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—